Quest Diagnostics, Inc. (DGX) Posts Mixed Q2 Results; Guides FY11 EPS In-Line
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $237.14 -0.94%
Revenue Growth %: +7.8%
Financial Fact:
Net income: 205M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +7.8%
Financial Fact:
Net income: 205M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 adjusted EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.92 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
